Get Social With Us

BioProcess Technology Consultants’ Levine, Jones and Kanarek Featured at BIO International Convention

Date: May 11, 2009
Location: Acton, Massachusetts

Howard L. Levine, Ph.D., President, Susan Dana Jones, Ph.D., Vice President and Senior Consultant, and Alex Kanarek, Ph.D., Senior Consultant, of BioProcess Technology Consultants will be featured speakers at the 2009 BIO International Convention, May 18-22, in Atlanta, Georgia.

Dr. Levine will chair a roundtable session in the Manufacturing Breakout Session of the main conference at 2:00 PM on Monday, May 18, and will speak on “A World of Biomanufacturing: Shortages or Global Glut?” He will highlight the fast-changing economics and range of global models emerging for biomanufacturing and how these new approaches impact the global supply and demand for biomanufacturing capacity. On Wednesday, May 20, Dr. Levine will also be interviewed by Jim Miller of PharmSource Information Services at the BioPharm Vidcasting & Networking Theatre Booth #2851 in the BIO Exhibition Hall. He will talk on “Outsourcing Capacity & Decision-Making,” covering the many strategic manufacturing decisions required throughout product development, the pros and cons of alternate manufacturing systems, and updates on cell culture and microbial fermentation capacity.

Dr. Jones will discuss “Challenges in Vaccine Production and Rapid Scale-Up to Meet Emerging Pandemic Threat,” at 10:30 AM on Wednesday, May 20, including alternative production methods for influenza vaccines that could speed up response to potential pandemics and improve the economics of vaccine manufacturing. Dr. Kanarek will provide an analysis of the 2008 FDA Draft Guidance on Process Validation in his presentation “Process Validation for the 21st Century” at 10:30 AM on Thursday, May 21.  Dr. Jones and Dr. Kanarek will speak at the BioProcess International BioProcess Product Focus Zone, Booth #5113 in the BIO Exhibition Hall. They are both on the Editorial Advisory and Peer Review Board of BioProcess International.

“The BIO International Convention is the foremost gathering of the industry’s innovators, business leaders, and decision makers, and we are pleased to be a part of this global event,” said Dr. Levine. “Our presentations will provide valuable information to conference attendees, allowing them to benefit from our insight and experience in the development and manufacturing of biologic products.”

Further details on the presentations and interview may be found at the BIO conference website at

About BioProcess Technology Consultants, Inc.
Founded in 1994, BioProcess Technology Consultants provides a full range of strategic, technical, business, and regulatory assistance to pharmaceutical and biotechnology companies in the development and commercialization of new biopharmaceutical products. The company specializes in helping clients to develop manufacturing processes and strategies and assists in developing product discovery and process development programs that help speed products from clone to commercial®. BioProcess Technology Consultants also helps investors make informed decisions by providing technical and business evaluations of new products and technologies and product discovery, development, and commercialization plans of potential investments and existing portfolio companies. For more about BioProcess Technology Consultants, visit